APA citiranje

Wainberg, M., Anstett, K., Mesplede, T., Quashie, P., Han, Y., & Oliveira, M. (2014). The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound. J Int AIDS Soc.

Citação norma Chicago

Wainberg, Mark, Kaitlin Anstett, Thibault Mesplede, Peter Quashie, Yingshan Han, and Maureen Oliveira. "The R263K Mutation in HIV Integrase That Is Selected By Dolutegravir May Actually Prevent Clinically Relevant Resistance to This Compound." J Int AIDS Soc 2014.

MLA citiranje

Wainberg, Mark, et al. "The R263K Mutation in HIV Integrase That Is Selected By Dolutegravir May Actually Prevent Clinically Relevant Resistance to This Compound." J Int AIDS Soc 2014.